RadNet (Nasdaq:RDNT) - Cotización, noticias y análisis

Resumen de acción RDNT

RadNet, Inc. y sus filiales prestan servicios ambulatorios de diagnóstico por imagen en Estados Unidos.

RDNT fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	3/6
Past Performance	1/6
Financial Health	3/6
Dividends	0/6

Recompensas

Se prevé un crecimiento anual de los beneficios de 81.73%

Análisis de riesgos

Los pagos de intereses no están bien cubiertos por los beneficios

Los márgenes de beneficio (0.2%) son inferiores a los del año pasado (0.7%)

Los accionistas han sido diluidos en el último año

Competidores de RadNet, Inc.

CorVel

NasdaqGS:CRVL

US$4.1b

Option Care Health

NasdaqGS:OPCH

US$5.2b

Amedisys

NasdaqGS:AMED

US$3.0b

R1 RCM

NasdaqGS:RCM

US$5.2b

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for RadNet
Historical stock prices
Current Share Price	US$51.20
52 Week High	US$52.40
52 Week Low	US$25.11
Beta	1.71
1 Month Change	4.40%
3 Month Change	37.82%
1 Year Change	78.52%
3 Year Change	120.03%
5 Year Change	280.67%
Change since IPO	5,020.00%

Noticias y actualizaciones recientes

Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?

Apr 08

Recent updates

An Intrinsic Calculation For RadNet, Inc. (NASDAQ:RDNT) Suggests It's 41% Undervalued

Nov 26

RadNet JV acquires Montclair Radiology's outpatient radiology assets

Oct 11

Some Investors May Be Worried About RadNet's (NASDAQ:RDNT) Returns On Capital

Oct 10

RadNet Presents With The Idiosyncratic Risk Premia To Deliver Risk-Adjusted Alpha

Aug 28

Here's Why RadNet (NASDAQ:RDNT) Has A Meaningful Debt Burden

Aug 12

RadNet Non-GAAP EPS of $0.15 beats by $0.06, revenue of $354.1M beats by $5.16M;reaffirms FY guidance

Aug 09

RadNet (NASDAQ:RDNT) Is Reinvesting At Lower Rates Of Return

Jul 01

Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?

Jun 17

Is RadNet (NASDAQ:RDNT) A Risky Investment?

May 11

Estimating The Intrinsic Value Of RadNet, Inc. (NASDAQ:RDNT)

Apr 06

Is RadNet (NASDAQ:RDNT) Using Too Much Debt?

Jan 24

Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled

Dec 23

Is RadNet, Inc. (NASDAQ:RDNT) Potentially Undervalued?

Dec 08

RadNet, Inc.'s (NASDAQ:RDNT) Intrinsic Value Is Potentially 35% Above Its Share Price

Nov 23

RadNet (NASDAQ:RDNT) Has A Pretty Healthy Balance Sheet

Oct 22

RadNet: An Essential Healthcare Services Stock Seen Underpriced By Market-Makers

Sep 03

Returns At RadNet (NASDAQ:RDNT) Appear To Be Weighed Down

Sep 01

Rentabilidad de los accionistas

	RDNT	US Healthcare	Mercado US
7D	5.8%	-1.9%	0.7%
1Y	78.5%	-0.1%	23.9%

Rentabilidad vs. Industria: RDNT superó al sector US Healthcare , que obtuvo un rendimiento del 1% el año pasado.

Rentabilidad vs. Mercado: RDNT superó al mercado US, que obtuvo un rendimiento del 19.3% el año pasado.

Volatilidad de los precios

Is RDNT's price volatile compared to industry and market?
RDNT volatility
RDNT Average Weekly Movement	6.5%
Healthcare Industry Average Movement	7.5%
Market Average Movement	6.1%
10% most volatile stocks in US Market	16.6%
10% least volatile stocks in US Market	3.0%

Precio estable de las acciones: El precio de las acciones de RDNT ha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de RDNT (7%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
1981	8,157	Howard Berger	www.radnet.com

RadNet, Inc. y sus filiales prestan servicios de diagnóstico por imagen a pacientes ambulatorios en Estados Unidos. La empresa opera en dos segmentos: Centros de diagnóstico por imagen e Inteligencia Artificial. Sus servicios incluyen resonancia magnética, tomografía computarizada, tomografía por emisión de positrones, medicina nuclear, mamografía, ecografía, radiología diagnóstica, fluoroscopia y otros procedimientos relacionados, así como servicios de imagen multimodalidad.

Resumen de fundamentos de RadNet, Inc.

¿Cómo se comparan los beneficios e ingresos de RadNet con su capitalización de mercado?
Estadísticas fundamentales de RDNT
Capitalización bursátil	US$3.78b
Beneficios(TTM)	US$3.04m
Ingresos (TTM)	US$1.62b

1,243x

Ratio precio-beneficio (PE)

2.3x

Ratio precio-ventas (PS)

¿Está RDNT sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de RDNT
Ingresos	US$1.62b
Coste de los ingresos	US$1.25b
Beneficio bruto	US$367.58m
Otros gastos	US$364.53m
Beneficios	US$3.04m

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

May 09, 2024

Beneficios por acción (BPA)	0.041
Margen bruto	22.74%
Margen de beneficio neto	0.19%
Ratio deuda/patrimonio	102.1%

¿Cómo se ha desempeñado RDNT a largo plazo?

Ver rendimiento histórico y comparativa

Resumen de acción RDNT

Recompensas

Análisis de riesgos

Competidores de RadNet, Inc.

NasdaqGS:CRVL

US$4.1b

NasdaqGS:OPCH

US$5.2b

NasdaqGS:AMED

US$3.0b

NasdaqGS:RCM

US$5.2b

Historial de precios y rendimiento

Noticias y actualizaciones recientes

RadNet, Inc., Annual General Meeting, Jun 12, 2024

Price target increased by 7.0% to US$53.33

Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?

Now 21% overvalued after recent price rise

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $200.2 million.

Consensus EPS estimates increase by 12%

Recent updates

RadNet, Inc., Annual General Meeting, Jun 12, 2024

Price target increased by 7.0% to US$53.33

Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?

Now 21% overvalued after recent price rise

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $200.2 million.

Consensus EPS estimates increase by 12%

RadNet, Inc.'s (NASDAQ:RDNT) 26% Price Boost Is Out Of Tune With Revenues

Price target increased by 12% to US$45.80

Now 21% overvalued after recent price rise

Full year 2023 earnings: EPS misses analyst expectations

Why RadNet, Inc. (NASDAQ:RDNT) Could Be Worth Watching

RadNet, Inc. Stock Price Is More Vigorous Than Its Valuation

Getting In Cheap On RadNet, Inc. (NASDAQ:RDNT) Might Be Difficult

Insider recently sold US$354k worth of stock

Insider notifies of intention to sell stock

RadNet, Inc. Launches a Pilot Inside Walmart of its New MammogramNow™ Offering

We Think RadNet (NASDAQ:RDNT) Can Stay On Top Of Its Debt

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

RadNet (NASDAQ:RDNT) Might Be Having Difficulty Using Its Capital Effectively

New major risk - Financial position

RadNet, Inc. Appoints Dr. Gregory Sorensen as Executive Vice President and Chief Science Officer

RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt

Radnet, Inc. Revises Earnings Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

RadNet, Inc. Announces Appointment of Executives

Consensus EPS estimates upgraded to US$0.10 loss

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $225.35625 million.

President & COO of Western Operations recently sold US$1.4m worth of stock

RadNet, Inc. Announces Ruth V. Wilson Did Not to Stand for Re-Election to the Board of Directors

President & COO of Western Operations exercised options to buy US$1.5m worth of stock.

RadNet, Inc., Annual General Meeting, Jun 07, 2023

Board Member recently sold US$138k worth of stock

RadNet, Inc. Revises Earnings Guidance for the Year 2023

Price target increased by 7.8% to US$34.50

We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt

President & COO of Eastern Operations recently sold US$230k worth of stock

Insider recently sold US$443k worth of stock

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

RadNet (NASDAQ:RDNT) Will Want To Turn Around Its Return Trends

Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program, Providing Women A New State-Of-The-Art Solution Powered by Artificial Intelligence

President & COO of Western Operations recently sold US$97k worth of stock

RadNet (NASDAQ:RDNT) Has A Somewhat Strained Balance Sheet

An Intrinsic Calculation For RadNet, Inc. (NASDAQ:RDNT) Suggests It's 41% Undervalued

Consensus forecasts updated

Third quarter 2022 earnings: EPS misses analyst expectations

RadNet, Inc. Provides Earnings Guidance for the Full Year of 2022

Investor sentiment deteriorated over the past week

RadNet, Inc. (NasdaqGM:RDNT) acquired 75% stake in Heart & Lung Imaging Limited.

RadNet JV acquires Montclair Radiology's outpatient radiology assets

Some Investors May Be Worried About RadNet's (NASDAQ:RDNT) Returns On Capital

Price target decreased to US$32.25

Investor sentiment improved over the past week

RadNet Presents With The Idiosyncratic Risk Premia To Deliver Risk-Adjusted Alpha

Investor sentiment improved over the past week

Here's Why RadNet (NASDAQ:RDNT) Has A Meaningful Debt Burden

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

RadNet, Inc. Updates Earnings Guidance for 2022